Finding Love in the New Normal
Karri Bland was diagnosed with breast cancer a little over a year ago and is currently in the midst of her treatment. It began in March 2023 when she found a lump in her right breast. She promptly scheduled a visit with her OBGYN, hoping for reassurance. Despite initial optimism, subsequent tests revealed nine lumps, culminating in a diagnosis of Invasive Ductal Carcinoma ER/PR+ HER2+. At only 33 years old, she found herself thrust into the bewildering journey of cancer treatment.
Karri first learned about the Susan G. Komen website through her care team’s recommendation, and it became her initial source of information on breast cancer. Exploring the website left her feeling more knowledgeable about her condition. It empowered her to discuss her journey with her family and helped them navigate the unfamiliar territory together.
In May 2023, consultations with her oncologist and surgeon initiated a rigorous treatment plan, including TCHP chemotherapy. Despite the grueling side effects, she persevered, supported by loved ones. September 6, 2023 marked the end of her chemotherapy, a milestone she celebrated with ringing bells and hopeful anticipation.
However, genetic testing from August 2023 revealed a heightened risk of breast and pancreatic cancer, and on October 13th, 2023, she had a double mastectomy and lymph node removal, necessitating a brave confrontation with her altered physique.
“It’s okay to grieve the lives you didn’t get to live and love the new normal you are living. Grief and love can coincide with each other,” said Karri.
In November 2023, her oncologist recommended 14 more rounds of chemotherapy, this time with TDM-1, a mix of chemotherapy and hormone therapy. December 2023 was packed with hopeful events like her son’s birthday, Christmas, and the New Year, but it also marked the commencement of her radiation treatment.
Despite complications with radiation, causing sunburn and infection that would delay her reconstruction until 2025, she completed it triumphantly in February 2024. Confronted with asymmetry, she finds solace in the newfound freedom of “not having anything in front of her.”
Karri’s advice to young adults is to advocate for themselves persistently, speak up if treatment feels wrong, and cultivate a supportive network. She recommends regular check-ins with social workers for both financial and emotional support, emphasizing that seeking therapy is valuable, not a weakness.
Regarding her involvement with Komen, Karri had long been aware of the Race for the Cure but had never participated until last year. She recalls passing by a young boy holding a sign that read “You can do this,” which moved her to tears, considering her recent diagnosis. Witnessing the resilience of women who had endured similar challenges was deeply inspiring. Crossing the finish line and receiving flowers while “Here Comes the Sun” played stirred many feelings, evoking memories of her father, who had passed away from cancer in 2017. Karri stopped working shortly after her diagnosis, and the grant provided by Komen alleviated some of her fears about the uncertain future. She finds joy in joining the Race for the Cure, supported by a caring community.
“You can do this. You still have time. Do not stop living your life, this is a diagnosis, not a death sentence,” said Karri.
Karri eagerly anticipates the completion of TDM-1 treatment in December 2024, marking the end of active treatment and appointments.
It’s okay to grieve the lives you didn’t get to live and love the new normal you are living. Grief and love can coincide with each other.